Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
223.6 USD | -1.24% |
|
-3.03% | -13.57% |
06-13 | REGENXBIO Inc. Announces Chief Executive Officer Changes | CI |
06-12 | Biogen executive plays down looming competition for its Alzheimer's drug | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.57% | 32.56B | |
+1.43% | 94.45B | |
-0.66% | 38.9B | |
+71.55% | 28.34B | |
-12.73% | 15.98B | |
-2.15% | 13.82B | |
-13.59% | 11.34B | |
+158.88% | 9.81B | |
-52.04% | 9.67B | |
+2.47% | 8.91B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen, Eisai Say Alzheimer's Maintenance Treatment Application Accepted by US FDA